The present invention provides compounds of formula I:
##STR1##
wherein A is N or CR, and G, R1, R2 and R3 are
as described in the specification. These compounds are inhibitors of protein kinase,
particularly inhibitors of Src mammalian protein kinase involved in cell proliferation,
cell death and response to extracellular stimuli. The invention also relates to
methods for producing these inhibitors. The invention also provides pharmaceutical
compositions comprising the inhibitors of the invention and methods of utilizing
those compositions in the treatment and prevention of various disorders.
